Gastroenterology and Hepatology

Episodes 1-16 of 21

• 

  RestartResume

  IBD & Pain: Integrating Multidisciplinary Approaches for Better Patient Outcomes

  RestartResume

  IBD & Pain: Integrating Multidisciplinary Approaches for Better Patient Outcomes

  CME/CE

  IBD & Pain: Integrating Multidisciplinary Approaches for Better Patient Outcomes

  • 

    

    Laurie Keefer, PhD

  • 

    

    Ruthvik K. Padival, MD

• 

  RestartResume

  What is New in Anti -TNFs and Anti-Integrins?

  RestartResume

  What is New in Anti -TNFs and Anti-Integrins?

  CME/CE

  What is New in Anti -TNFs and Anti-Integrins?

  0.50 credits

  • 

    

    Joel Pekow, MD, MPH

  0.50 credits

• 

  RestartResume

  IL-12/23 and IL-23 Receptor Antagonists

  RestartResume

  IL-12/23 and IL-23 Receptor Antagonists

  CME/CE

  IL-12/23 and IL-23 Receptor Antagonists

  0.50 credits

  • 

    

    Sara Horst, MD, MPH

  0.50 credits

• 

  RestartResume

  IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going

  RestartResume

  IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going

  CME/CE

  IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going

  0.50 credits

  • 

    

    Matthew Ciorba, MD

  0.50 credits

• 

  RestartResume

  Small Molecules (JAKi/S1P agonists)

  RestartResume

  Small Molecules (JAKi/S1P agonists)

  CME/CE

  Small Molecules (JAKi/S1P agonists)

  0.50 credits

  • 

    

    Kara DeFelice, MD

  0.50 credits

• 

  RestartResume

  IBD and Biosimilars: What Healthcare Professionals Need to Know

  RestartResume

  IBD and Biosimilars: What Healthcare Professionals Need to Know

  GI Insights

  IBD and Biosimilars: What Healthcare Professionals Need to Know

  • 

    

    Ross M. Maltz, MD

  • 

    

    Shail M. Govani, MD, MSc

  • 

    

    Nana E. Bernasko, CRNP, WHNP-BC, DNP

  • 

    

    Shubha Bhat, PharmD, MS, BCACP

• 

  RestartResume

  Crohn’s & Colitis Congress 2022: A Look at Diet & Nutrition Therapies 

  RestartResume

  Crohn’s & Colitis Congress 2022: A Look at Diet & Nutrition Therapies 

  Crohn’s & Colitis Foundation Perspectives

  Crohn’s & Colitis Congress 2022: A Look at Diet & Nutrition Therapies 

  • 

    

    Jennifer Caudle, DO

  • 

    

    Maitreyi Raman , MD, MSc, FRCPC

• 

  RestartResume

  Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair 

  RestartResume

  Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair 

  Crohn’s & Colitis Foundation Perspectives

  Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair 

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Peter D. Higgins, MD, PhD

• 

  RestartResume

  Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care

  RestartResume

  Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care

  Crohn’s & Colitis Foundation Perspectives

  Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care

  • 

    

    Jennifer Caudle, DO

  • 

    

    Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI

• 

  RestartResume

  Exploring the ACE Index in Acute Ulcerative Colitis

  RestartResume

  Exploring the ACE Index in Acute Ulcerative Colitis

  AudioAbstracts

  Exploring the ACE Index in Acute Ulcerative Colitis

  • 

    

    Esteban Figueroa, MD

• 

  RestartResume

  Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis 

  RestartResume

  Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis 

  Crohn’s & Colitis Foundation Perspectives

  Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis 

  • 

    

    Jordan E. Axelrad, MD, MPH

• 

  RestartResume

  Keeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes

  RestartResume

  Keeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes

  Crohn’s & Colitis Foundation Perspectives

  Keeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes

  • 

    

    Xiaohong Wang, MD, PhD

• 

  RestartResume

  Crohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being

  RestartResume

  Crohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being

  Crohn’s & Colitis Foundation Perspectives

  Crohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being

  • 

    

    Tina Aswani Omprakash

• 

  RestartResume

  Crohn’s & Colitis Congress 2021: Challenges & Approaches to Managing IBD in the COVID-19 Era

  RestartResume

  Crohn’s & Colitis Congress 2021: Challenges & Approaches to Managing IBD in the COVID-19 Era

  Crohn’s & Colitis Foundation Perspectives

  Crohn’s & Colitis Congress 2021: Challenges & Approaches to Managing IBD in the COVID-19 Era

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Frank Scott

• 

  RestartResume

  Crohn’s & Colitis Congress 2021: The Future of IBD Treatments

  RestartResume

  Crohn’s & Colitis Congress 2021: The Future of IBD Treatments

  Crohn’s & Colitis Foundation Perspectives

  Crohn’s & Colitis Congress 2021: The Future of IBD Treatments

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Siddharth Singh, MD

• 

  RestartResume

  Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD

  RestartResume

  Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD

  Crohn’s & Colitis Foundation Perspectives

  Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Maria M. Oliva-Hemker, MD

• Prev
• 1
• 2
• Next